everolimus
Also known as RAD001, SDZ-RAD, 40-O-(2-hydroxyethyl)-rapamycin, 42-O-(2-hydroxyethyl)rapamycin
Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants and as a targeted therapy in the treatment of renal cell cancer and other tumours.
Key facts
- Drug.MedlinePlus
- a609032
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 459441923
- Drug.image
- Everolimus.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Everolimus ball-and-stick.png
- Drug.image_class2
- bg-transparent
- Drug.pronounce
- Everolimus
- Drug.tradename
- Afinitor, Zortress
- Drug.DailyMedID
- Everolimus
- Drug.pregnancy_AU
- C
- Drug.routes_of_administration
~9 min read
Article
11 sectionsContents
- Medical uses
- UK National Health Service
- Clinical trials
- Mechanism
- Adverse reactions
- Role in heart transplantation
- Role in liver transplantation
- Use in vascular stents
- Use in aging
- References
- Further reading
Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants and as a targeted therapy in the treatment of renal cell cancer and other tumours.
This compound also has a use in cardiovascular drug-eluting stent technologies to inhibit restenosis.